Evidence map›Paper›PMID 36721642›Full record

ArticleEJHaem2022

A third dose of COVID-19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant.

Takashi Toya, Daichi Sadato, Takahiro Sanada, Tomoko Honda, Yuya Atsuta, Noritaka Sekiya, Hiroaki Shimizu, Yuho Najima, Takeshi Kobayashi, Yuka Harada and 2 more

Open access · diamondAbstract read
In one paragraph

Article in EJHaem, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Takashi ToyaHematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan.ORCID https://orcid.org/0000-0002-7436-972X
Daichi SadatoClinical Research Support Center Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan.
Takahiro SanadaDepartment of Microbiology and Cell Biology Tokyo Metropolitan Institute of Medical Science Tokyo Japan.
Tomoko HondaDepartment of Microbiology and Cell Biology Tokyo Metropolitan Institute of Medical Science Tokyo Japan.
Yuya AtsutaHematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan.
Noritaka SekiyaDepartment of Infection Prevention and Control Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan.
Hiroaki ShimizuHematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan.
Yuho NajimaHematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan.ORCID https://orcid.org/0000-0001-8910-0021
Takeshi KobayashiHematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan.
Yuka HaradaClinical Research Support Center Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan.
Michinori KoharaDepartment of Microbiology and Cell Biology Tokyo Metropolitan Institute of Medical Science Tokyo Japan.
Noriko DokiHematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan.
Tokyo Metropolitan Komagome Hospital · JPTokyo Metropolitan Institute of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

allogeneic hematopoietic stem cell transplantationCOVID‐19humoral immunitymRNA vaccineSARS‐CoV‐2

Identifiers

PMID36721642
PMCPMC9880636
OpenAlexW4312164526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.